Expression profiling of renal epithelial neoplasms: a method for tumor classification and discovery of diagnostic molecular markers.

[1]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[2]  S. Tickoo,et al.  Ultrastructural Observations on Mitochondria and Microvesicles in Renal Oncocytoma, Chromophobe Renal Cell Carcinoma, and Eosinophilic Variant of Conventional (Clear Cell) Renal Cell Carcinoma , 2000, The American journal of surgical pathology.

[3]  G. A. Whitmore,et al.  Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[4]  N. Sampas,et al.  Molecular classification of cutaneous malignant melanoma by gene expression profiling , 2000, Nature.

[5]  V. Hogan,et al.  Decreased galectin‐3 expression in prostate cancer , 2000, The Prostate.

[6]  H. Hiai,et al.  Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress. , 2000, The American journal of pathology.

[7]  M. Kagnoff,et al.  Analysis by High Density cDNA Arrays of Altered Gene Expression in Human Intestinal Epithelial Cells in Response to Infection with the Invasive Enteric BacteriaSalmonella * , 2000, The Journal of Biological Chemistry.

[8]  R. Bukowski.  Cytokine combinations: therapeutic use in patients with advanced renal cell carcinoma. , 2000, Seminars in oncology.

[9]  R. Motzer,et al.  Novel investigative approaches for advanced renal cell carcinoma. , 2000, Seminars in oncology.

[10]  N. Tinari,et al.  Concentrations of galectin-3 in the sera of normal controls and cancer patients. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[11]  Ash A. Alizadeh,et al.  Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.

[12]  Y. Collan,et al.  Cathepsin H expression distinguishes oncocytomas from renal cell carcinomas. , 2000, Anticancer research.

[13]  J. Buhler,et al.  Serial microanalysis of renal transcriptomes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  Laurie J. Heyer,et al.  Exploring expression data: identification and analysis of coexpressed genes. , 1999, Genome research.

[15]  J. Mesirov,et al.  Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.

[16]  W. Linehan,et al.  Histopathology and molecular genetics of renal tumors toward unification of a classification system. , 1999, The Journal of urology.

[17]  M. Rubin,et al.  Renal oncocytosis: a morphologic study of fourteen cases. , 1999, The American journal of surgical pathology.

[18]  R. Kiss,et al.  Galectin-1 and galectin-3 binding pattern expression in renal cell carcinomas. , 1999, American journal of clinical pathology.

[19]  R. Ve.  Renal tumors exhibiting granular cytoplasm. , 1999 .

[20]  H. Moch,et al.  High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma. , 1999, The American journal of pathology.

[21]  D. Shibata.  Pattern recognition and arrays: the times are a-changing. , 1999, The American journal of pathology.

[22]  V. Reuter.  Renal tumors exhibiting granular cytoplasm. , 1999, Seminars in diagnostic pathology.

[23]  Taylor Murray,et al.  Cancer statistics, 1999 , 1999, CA: a cancer journal for clinicians.

[24]  P. Brown,et al.  DNA arrays for analysis of gene expression. , 1999, Methods in enzymology.

[25]  D. Botstein,et al.  Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Braun,et al.  Cytogenetic analysis of 11 renal oncocytomas: further evidence of structural rearrangements of 11q13 as a characteristic chromosomal anomaly. , 1998, Cancer genetics and cytogenetics.

[27]  S. Naylor,et al.  Physical and functional mapping of a tumor suppressor locus for renal cell carcinoma within chromosome 3p12. , 1998, Cancer research.

[28]  H. Idikio.  Galectin-3 expression in human breast carcinoma: correlation with cancer histologic grade. , 1998, International journal of oncology.

[29]  Christina H. Park,et al.  Human beta-defensin-1: an antimicrobial peptide of urogenital tissues. , 1998, The Journal of clinical investigation.

[30]  B. Hoffman,et al.  AP-1 (Fos/Jun) transcription factors in hematopoietic differentiation and apoptosis. , 1998, International journal of oncology.

[31]  S. Tickoo,et al.  Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. , 1999, The American journal of surgical pathology.

[32]  E. van den Berg,et al.  Renal oncocytoma with t(5;12;11), der(1)t(1;8) and add(19): “true” oncocytoma or chromophobe adenoma? , 1997, International journal of cancer.

[33]  M. Ali,et al.  Sarcomatoid renal cell carcinoma: the chromophobe connection. , 1997, The American journal of surgical pathology.

[34]  C. Buys,et al.  Involvement of multiple loci on chromosome 3 in renal cell cancer development , 1997, Genes, chromosomes & cancer.

[35]  Y. Tomita,et al.  Erratum to ‘MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host’ [Cancer Lett. 109 (1996), 15–21] , 1997 .

[36]  R. W. Davis,et al.  Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[37]  P. Bugert,et al.  Specific genetic changes of diagnostic importance in chromophobe renal cell carcinomas. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[38]  Y. Tomita,et al.  MHC class II antigen-associated invariant chain on renal cell cancer may contribute to the anti-tumor immune response of the host. , 1996, Cancer letters.

[39]  A. Renshaw,et al.  Aggressive variants of chromophobe renal cell carcinoma , 1996, Cancer.

[40]  D. Bostwick,et al.  Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1. , 1996, The Journal of urology.

[41]  M. Newton,et al.  The correlation between the loss of chromosome 14q with histologic tumor grade, pathologic stage, and outcome of patients with nonpapillary renal cell carcinoma. , 1996, Cancer.

[42]  F. Waldman,et al.  Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. , 1996, Cancer research.

[43]  T. Ishikawa,et al.  Mutations of the p53 gene and p53 protein overexpression are associated with sarcomatoid transformation in renal cell carcinomas. , 1995, Cancer research.

[44]  W. Linehan,et al.  Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications. , 1995, The Journal of urology.

[45]  A. Norton,et al.  Brief, high‐temperature heat denaturation (pressure cooking): A simple and effective method of antigen retrieval for routinely processed tissues , 1994, The Journal of pathology.

[46]  J. Brooks,et al.  Mutations of the VHL tumour suppressor gene in renal carcinoma , 1994, Nature Genetics.

[47]  K. Batts,et al.  Cytogenetic analysis of six renal oncocytomas and a chromophobe cell renal carcinoma. Evidence that -Y, -1 may be a characteristic anomaly in renal oncocytomas. , 1992, Cancer genetics and cytogenetics.

[48]  G. Kovacs,et al.  Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas , 1992, The Journal of pathology.

[49]  G. Kovacs,et al.  Low chromosome number in chromophobe renal cell carcinomas , 1992, Genes, chromosomes & cancer.

[50]  P. Schofield,et al.  The role of insulin-like growth factors and IGF-binding proteins in the physiological and pathological processes of the kidney , 1992, Virchows Archiv. B, Cell pathology including molecular pathology.

[51]  M. Ortmann,et al.  Sialylated glycoconjugates in chromophobe cell renal carcinoma compared with other renal cell tumors , 1992, Virchows Archiv. B, Cell pathology including molecular pathology.

[52]  R. Bindels,et al.  Calbindin-D9k and parvalbumin are exclusively located along basolateral membranes in rat distal nephron. , 1991, Journal of the American Society of Nephrology : JASN.

[53]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[54]  S. Störkel,et al.  The human chromophobe cell renal carcinoma: Its probable relation to intercalated cells of the collecting duct , 1988, Virchows Archiv. B, Cell pathology including molecular pathology.

[55]  R. Moll,et al.  Chromophobe cell renal carcinoma and its variants—a report on 32 cases , 1988, The Journal of pathology.

[56]  R. C. Nairn,et al.  Renal tubular antigens in kidney tumors , 1972, Cancer.